PetMed Express (PETS) Set to Post Earnings on Tuesday

PetMed Express (NASDAQ:PETS) is expected to release its Q2 2027 results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $62.00 million for the quarter. Interested persons may visit the company’s upcoming Q2 2027 earnings report page for the latest details on the call scheduled for Tuesday, November 10, 2026 at 4:30 PM ET.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.40). PetMed Express had a negative net margin of 17.34% and a negative return on equity of 91.69%. The company had revenue of $41.02 million for the quarter, compared to analysts’ expectations of $71.00 million. On average, analysts expect PetMed Express to post ($0.50) EPS for the current fiscal year and ($0.35) EPS for the next fiscal year.

PetMed Express Price Performance

PetMed Express stock opened at $1.22 on Monday. PetMed Express has a twelve month low of $1.15 and a twelve month high of $4.10. The company’s 50-day moving average price is $1.43 and its 200-day moving average price is $2.07. The company has a market cap of $26.45 million, a PE ratio of -0.88 and a beta of 0.82.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Morgan Stanley dropped their target price on shares of PetMed Express from $2.15 to $1.40 and set an “underweight” rating on the stock in a research note on Friday, September 25th. Zacks Research cut shares of PetMed Express from a “hold” rating to a “strong sell” rating in a report on Friday, September 25th. Weiss Ratings raised PetMed Express from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, October 14th. Finally, Wall Street Zen cut shares of PetMed Express from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Three analysts have rated the stock with a Sell rating. According to MarketBeat, the company has an average rating of “Strong Sell” and a consensus target price of $1.40.

PetMed Express Company Profile

PetMed Express, Inc, doing business as PetMeds, is an online retailer of prescription and nonprescription medications and health products for dogs, cats and other household pets. The company offers products used to treat or prevent conditions such as allergies, infections, parasites and chronic illnesses, including prescription medicines, flea and tick treatments, heartworm preventatives, supplements and other animal-health products.

In addition to medications, PetMeds sells pet food, treats, vitamins, wellness products and selected supplies.